Risk-Adapted Therapy for Young Children With Embryonal Brain
Tumors, Choroid Plexus Carcinoma, High Grade Glioma or
Ependymoma Information source: St. Jude Children's Research
Hospital Information obtained from ClinicalTrials.gov on
February 07, 2013 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Brain and Central Nervous System Tumors
Intervention: Induction Chemotherapy (Drug); Low-Risk Therapy
(Drug); High-Risk Therapy (Drug); Intermediate-Risk Therapy
(Drug) Sponsored by: St. Jude Children's Research Hospital
Official(s) and/or principal investigator(s): Amar Gajjar, MD,
Study Chair, Affiliation: St. Jude Children's Research Hospital
Amar Gajjar, MD, Phone: 1-866-278-5833, Email: email@example.com
RATIONALE: In this study a combination of anti-cancer drugs
(chemotherapy) is used to treat brain tumors in young children.
Using chemotherapy gives the brain more time to develop before
radiation is given. The chemotherapy in this study includes the
drug methotrexate. This drug was an imp